Table 2.
Characteristics of 563 febrile neutropenia episodes.
| Patient characteristics | Total(n = 563) |
|---|---|
| Median (range) duration of fever prior to admission (days) | 1 (0, 60) |
| Interval since the last chemotherapy (days) (median, range) | 10 (0, 148) |
| Therapy preceding infection, n (%) | |
| Induction | 155 (27.5%) |
| Maintenance | 68 (12.1%) |
| Disease status, n (%) | |
| Remission | 58 (21.7%) |
| Not remission | 43 (16.1%) |
| Duration of neutropenia (days) (median, range) | 8 (1, 49) |
| Duration of fever in days (median, range) | 3 (1, 38) |
| White blood cell count on admission (cells/mm³) (median, range) | 670 (10, 2, 35, 150) |
| Absolute neutrophil count on admission (cells/mm³) (median, range) | 70 (0, 9, 522) |
| Antifungal therapy in the past 6 months | 123 (21.8%) |
| G-CSF use before a specific cycle | 164 (29.1%) |
| Steroid in the past 14 days | 226 (40.1%) |
| Central venous catheter | 226 (40.1%) |
| Central line | 111 (19.8%) |
| PICC line | 102 (18.1%) |
| Chemoport | 10 (1.8%) |
| Hickmann | 3 (0.5%) |